Kayla Rogers Klein

Kayla Rogers Klein is an experienced professional in patient advocacy and therapeutic policy, currently serving as Director of Global Therapeutic Policy and Patient Advocacy for Gastrointestinal programs at Takeda. Previous roles include Associate Director of Patient Advocacy at both Moderna and Sigilon Therapeutics, where Kayla also held positions as Manager and Lead for Patient Advocacy. Earlier career experience includes serving as a Patient Educator at Octapharma and as an 8th Grade Science Teacher at Newton Public Schools. Kayla holds a Master of Arts in Teaching from Simmons University and a Bachelor of Arts in Communication and Media Studies from Saint Mary's College.